Viewing Study NCT01723735


Ignite Creation Date: 2025-12-24 @ 10:12 PM
Ignite Modification Date: 2025-12-29 @ 8:17 PM
Study NCT ID: NCT01723735
Status: COMPLETED
Last Update Posted: 2016-09-28
First Post: 2012-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-11
Start Date Type: None
Primary Completion Date: 2013-07
Primary Completion Date Type: ACTUAL
Completion Date: 2013-07
Completion Date Type: ACTUAL
First Submit Date: 2012-11-06
First Submit QC Date: None
Study First Post Date: 2012-11-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-09-27
Last Update Post Date: 2016-09-28
Last Update Post Date Type: ESTIMATED